Sclerosing Sialadenitis Is Associated With Salivary Gland Hypofunction and a Unique Gene Expression Profile in Sjögren's Syndrome
Overview
Authors
Affiliations
Purpose: To develop a novel method to quantify the amount of fibrosis in the salivary gland and to investigate the relationship between fibrosis and specific symptoms associated with Sjögren's syndrome (SS) using this method.
Materials And Methods: Paraffin-embedded labial salivary gland (LSG) slides from 20 female SS patients and their clinical and LSG pathology data were obtained from the Sjögren's International Collaborative Clinical Alliance. Relative interstitial fibrosis area (RIFA) in Masson's trichrome-stained LSG sections was quantified from digitally scanned slides and used for correlation analysis. Gene expression levels were assessed by microarray analysis. Core promoter accessibility for RIFA-correlated genes was determined using DNase I hypersensitive sites sequencing analysis.
Results: RIFA was significantly correlated with unstimulated whole saliva flow rate in SS patients. Sixteen genes were significantly and positively correlated with RIFA. In a separate analysis, a group of differentially expressed genes was identified by comparing severe and moderate fibrosis groups. This combined set of genes was distinct from differentially expressed genes identified in lung epithelium from idiopathic pulmonary fibrosis patients compared with controls. Single-cell RNA sequencing analysis of salivary glands suggested most of the RIFA-correlated genes are expressed by fibroblasts in the gland and are in a permissive chromatin state.
Conclusion: RIFA quantification is a novel method for assessing interstitial fibrosis and the impact of fibrosis on SS symptoms. Loss of gland function may be associated with salivary gland fibrosis, which is likely to be driven by a unique set of genes that are mainly expressed by fibroblasts.
Fang R, Zhou Z, Chu R, Guan Q, He F, Ge M Acta Pharmacol Sin. 2024; 45(12):2611-2624.
PMID: 39054339 PMC: 11579508. DOI: 10.1038/s41401-024-01350-4.
Gupta S, Yamada E, Nakamura H, Perez P, Pranzatelli T, Dominick K Ann Rheum Dis. 2024; 83(8):1034-1047.
PMID: 38527764 PMC: 11250564. DOI: 10.1136/ard-2023-224842.
GZMK+CD8+ T cells Target A Specific Acinar Cell Type in Sjögren's Disease.
Pranzatelli T, Perez P, Ku A, Matuck B, Huynh K, Sakai S Res Sq. 2024; .
PMID: 38196575 PMC: 10775371. DOI: 10.21203/rs.3.rs-3601404/v1.
TScan-II: A genome-scale platform for the de novo identification of CD4 T cell epitopes.
Dezfulian M, Kula T, Pranzatelli T, Kamitaki N, Meng Q, Khatri B Cell. 2023; 186(25):5569-5586.e21.
PMID: 38016469 PMC: 10841602. DOI: 10.1016/j.cell.2023.10.024.
Nakamura H, Tanaka T, Zheng C, Afione S, Warner B, Noguchi M Arthritis Rheumatol. 2023; 75(9):1586-1598.
PMID: 37096570 PMC: 11132095. DOI: 10.1002/art.42540.